Th17 cells are suggested to be pathogenic in mediating experimental autoimmune encephalomyelitis (EAE), but their relation to interferon (IFN)-γ-producing Th1 cells in vivo is not well understood. We studied the numbers and functions of Th17 cells in CREAE in Biozzi ABH mice, both in peripheral lymphoid organs and in the central nervous system. Th1 and Th17 cells alternated in secondary lymphoid organs and infiltrated into the central nervous system during chronic relapsing experimental autoimmune encephalomyelitis (CREAE). In the absence of IFN-γ the numbers and secretion of Th17 cells was enhanced, whereas exogenous administration of IFN-γ decreased the Th17 cells. In mice with intact IFN-γ genes, in vivo neutralization of interleukin (IL)-17 protected against EAE development by enhancing the number of IFN-γ-producing cells. IFN-γ knockout mice were partially protected by anti-IL-17 antibodies by decreasing cell numbers and production of IL-17. Our findings suggest that, whereas IFN-γ as such is not necessary for EAE development in the mouse, the lack of suppression of Th17 cells by IFN-γ enhances the susceptibility to develop EAE. IFN-γ thus orchestrates the number and function of Th17 cells.
Get full access to this article
View all access options for this article.
References
1.
AggarwalS, GhilardiN, XieMH, de SauvageFJ, GurneyAL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem, 278:1910–1914.
2.
AggarwalS, GurneyAL. 2002. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol, 71:1–8.
3.
AxtellRC, XuL, BarnumSR, RamanC. 2006. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J Immunol, 177:8542–8549.
4.
BettelliE, OukkaM, KuchrooVK. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol, 8:345–350.
5.
BilliauA, HeremansH, VandekerckhoveF, DijkmansR, SobisH, MeulepasE, CartonH. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γJ Immunol, 140:1506–1510.
6.
BocekPJr., FoucrasG, PaulWE. 2004. Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production. J Exp Med, 199:1619–1630.
7.
BrownAM, McFarlinDE. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest, 45:278–284.
ChuCQ, SwartD, AlcornD, TockerJ, ElkonKB. 2007. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum, 56:1145–1151.
10.
CruzA, KhaderSA, TorradoE, FragaA, PearlJE, PedrosaJ, CooperAM, CastroAG. 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol, 177:1416–1420.
11.
DijkmansR, MartensE, BeukenE, CornetteF, DillenC, HeremansH, BoraschiD, BilliauA. 1991. Murine interferon-γ/interleukin-1 fusion protein used as antigens for the generation of hybridomas producing monoclonal anti-interleukin-1 antibodies. Cytokine, 3:134–140.
12.
DijkmansR, VolckaertG, Van DammeJ, De LeyM, BilliauA, De SomerP. 1985. Molecular cloning of murine interferon gamma (MuIFN-γ) cDNA and its expression in heterologous mammalian cells. J Interferon Res, 5:511–520.
13.
FerberIA, BrockeS, Taylor-EdwardsC, RidgwayW, DiniscoC, SteinmanL, DaltonD, FathmanCG. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)J Immunol, 156,1:5–7.
14.
GijbelsK, BrockeS, AbramsJS, SteinmanL. 1995. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous sytem and circulation. Mol Med, 1,7:795–805.
15.
HaakS, CroxfordAL, KreymborgK, HeppnerFL, PoulyS, BecherB, WaismanA. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest, 119:61–69.
16.
HarringtonLE, HattonRD, ManganPR, TurnerH, MurphyTL, MurphyKM, WeaverCT. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 6:1123–1132.
17.
HeremansH, DijkmansR, SobisH, VandekerckhoveF, BilliauA. 1987. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J Immunol, 138:4175–4179.
18.
HeremansH, DillenC, GroenenM, MartensE, BilliauA. 1996. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against IFN-γEur J Immunol, 26:2393–2398.
19.
HeremansH, Van DammeJ, DillenC, DijkmansR, BilliauA. 1990. Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med, 171:1853–1869.
20.
HofstetterHH, ForsthuberTG. 2010. Kinetics of IL-17- and interferon-gamma-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp/IFA with pertussis toxin in SJL mice. Neurosci Lett, 476:150–155.
IrmlerIM, GajdaM, BrauerR. 2007. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol, 179:6228–6236.
23.
IvanovII, McKenzieBS, ZhouL, TadokoroCE, LepelleyA, LafailleJJ, CuaDJ, LittmanDR. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 126:1121–1133.
24.
KomiyamaY, NakaeS, MatsukiT, NambuA, IshigameH, KakutaS, SudoK, IwakuraY. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol, 177:566–573.
25.
KornT, ReddyJ, GaoW, BettelliE, AwasthiA, PetersenTR, BackstromBT, SobelRA, WucherpfennigKW, StromTB, OukkaM, KuchrooVK. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med, 3:423–431.
KroenkeMA, CarlsonTJ, AndjelkovicAV, SegalBM. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med, 205:1535–1541.
28.
LangrishCL, ChenY, BlumenscheinWM, MattsonJ, BashamB, SedgwickJD, McClanahanT, KasteleinRA, CuaDJ. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med, 201:233–240.
LugerD, SilverPB, TangJ, CuaD, ChenZ, IwakuraY, BowmanEP, SgambelloneNM, ChanCC, CaspiRR. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med, 205:799–810.
32.
MatuseviciusD, KivisakkP, HeB, KostulasN, OzenciV, FredriksonS, LinkH. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler, 5:101–104.
33.
McGeachyMJ, ChenY, TatoCM, LaurenceA, Joyce-ShaikhB, BlumenscheinWM, McClanahanTK, O'SheaJJ, CuaDJ. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol, 10:314–324.
34.
MichelML, KellerAC, PagetC, FujioM, TrotteinF, SavagePB, WongCH, SchneiderE, DyM, Leite-de-MoraesMC. 2007. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med, 204:995–1001.
35.
MomcilovicM, MiljkovicZ, PopadicD, MiljkovicD, Mostarica-StojkovicM. 2008. Kinetics of IFN-gamma and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats. Neurosci Lett, 447:148–152.
36.
MurphyAC, LalorSJ, LynchMA, MillsKH. 2010. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun, 24:641–651.
37.
MurphyCA, LangrishCL, ChenY, BlumenscheinW, McClanahanT, KasteleinRA, SedgwickJD, CuaDJ. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med, 198:1951–1957.
38.
O'ConnorRA, PrendergastCT, SabatosCA, LauCW, LeechMD, WraithDC, AndertonSM. 2008. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol, 181:3750–3754.
39.
ParkH, LiZ, YangXO, ChangSH, NurievaR, WangYH, WangY, HoodL, ZhuZ, TianQ, DongC. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol, 6:1133–1141.
40.
RoarkCL, SimonianPL, FontenotAP, BornWK, O'BrienRL. 2008. Gammadelta T cells: an important source of IL-17. Curr Opin Immunol, 20:353–357.
41.
RuddleNH, BergmanCM, McGrathKM, LingenheldEG, GrunnetML, PadulaSJ, ClarkRB. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med, 172:1193–1200.
42.
SchroderK, HertzogPJ, RavasiT, HumeDA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75:163–189.
43.
SteinmanL. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med, 13:139–145.
44.
StromnesIM, CerrettiLM, LiggittD, HarrisRA, GovermanJM. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med, 14:337–342.
45.
SuryaniS, SuttonI. 2007. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J Neuroimmunol, 183:96–103.
46.
TagawaY, SekikawaK, IwakuraY. 1997. Suppression of concanavalin A-induced hepatitis in IFN-γ-/- mice, but not in TNF-α-/- mice. J Immunol, 159:1418–1428.
47.
TzartosJS, FrieseMA, CranerMJ, PalaceJ, NewcombeJ, EsiriMM, FuggerL. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol, 172:146–155.
48.
UyttenhoveC, Van SnickJ. 2006. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol, 36:2868–2874.
49.
WillenborgDO, FordhamS, BernardCCA, CowdenWB, RamshawIA. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol, 157,8:3223–3227.
50.
YangL, AndersonDE, Baecher-AllanC, HastingsWD, BettelliE, OukkaM, KuchrooVK, HaflerDA. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature, 454:350–352.
